CYTOKINETICS (NASDAQ:CYTK)

3.28

0.07 (2.09%)

CYTOKINETICS (NASDAQ:CYTK) Delayed :
Previous Close	$3.35	52 Week High	$5.55
Open	$3.25	52 Week Low	$1.39
Day High	$3.33	P/E	8.00
Day Low	$3.22	EPS	$0.41
Volume	155,158
More CYTK Info: Chart SEC Filings Profile Historical Options

What is this?Friends, Peers and Foes

Ticker	# Stories	Ticker	# Stories
FSLR	6	AMGN	5
SYMC	3	EGHT	3
FLS	3	AKAM	3
LMAT	3	LNC	3
CATM	3	CBT	2
JAH	2	ICO	2

View All Entities

Oct 28, 2009 04:46 PM Cytokinetics (CYTK) Reports Q3 Loss of $0.14
Jul 29, 2009 04:53 PM Cytokinetics (CYTK) Reports Q2 EPS of $0.98
Apr 30, 2009 04:04 PM Cytokinetics (CYTK) Falls Short of Q1 View; Re-affirms

Nov 19, 2009 08:28 AM Cytokinetics (CYTK) Presents Non-Clincial Data Relating to GSK-923295 at AACR-NCI-EORTC Int. Conference
Nov 18, 2009 10:55 AM Notable Analyst Rating Changes 11/18: SII, ZMH, FSLR, PHM Upgraded; TGT, ADSK, VIP, JEC, PARD Downgraded
Nov 18, 2009 09:32 AM Canaccord Adams Initiates Coverage on Cytokinetics (CYTK) with a Buy
Nov 17, 2009 08:54 AM Cytokinetics (CYTK) Announces Non-Clinical Smooth Muscle Contractility Presentations
Oct 29, 2009 01:15 PM Unusual 11 Mid-Day Movers 10/29: GIGA, REV, GKK, TBL Higher; TSPT, CPF, KSP, CYTK Lower

Nov 19, 2009 07:30AM Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 Presented at the 2009 AACR-NCI-EORTC International Conference
Nov 17, 2009 07:30AM Cytokinetics Presents Non-Clinical Data From Its Smooth Muscle Contractility Program at the 2009 Scientific Sessions of the American Heart Association
Nov 12, 2009 04:00PM Cytokinetics Announces Non-Clinical Data Relating to GSK-923295 to Be Presented at the 2009 AACR-NCI-EORTC International Conference
Nov 10, 2009 04:00PM Cytokinetics to Present Non-Clinical Data From Its Smooth Muscle Contractility Program at the 2009 Scientific Sessions of the American Heart Association
Nov 9, 2009 07:30AM Cytokinetics Announces Advancement of CK-2017357 in Phase I Clinical Trials

Sep 20, 2009 04:50 PM Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Aug 12, 2009 03:25 AM Cash for Cardiovascular: Who Might Be Next?
May 31, 2009 06:38 AM Two Potential Mega Biotech Deals Fuel Industry Hopes
Feb 10, 2009 10:22 PM Cytokinetics, Inc. Q4 2008 Earnings Call Transcript
Dec 30, 2008 04:57 AM 3 Top and Bottom Market Sectors for This Week

Nov 25, 2009 12:12PM Form 4 CYTOKINETICS INC For: Nov 24 Filed by: Blum Robert I
Nov 19, 2009 07:36AM Form 8-K CYTOKINETICS INC For: Nov 19
Nov 18, 2009 05:45PM Form 4 CYTOKINETICS INC For: Nov 17 Filed by: Sabry James H
Nov 17, 2009 06:32PM Form 4 CYTOKINETICS INC For: Nov 16 Filed by: BARBARI SHARON SURREY
Nov 17, 2009 06:31PM Form 4 CYTOKINETICS INC For: Nov 13 Filed by: Sabry James H

Nougatine1
on Nov 18, 2009
at 09:43 AM You took a long time to understand their potential... Since march-april 2009...It was already clear about this company potential...
Article: Canaccord Adams Initiates Coverage on Cytokinetics (CYTK) with a Buy

No comments are currently available.